Rheumatoid Arthritis and Hair Loss: Causes and Remedies – Everyday Health
One study found that 3.3 percent of the women with rheumatic diseases including RA who took the anti-TNF therapies etanercept […]
One study found that 3.3 percent of the women with rheumatic diseases including RA who took the anti-TNF therapies etanercept […]
Preview of RheumNow Live 2026 tammytilley@gm… Tue, 12/09/2025 – 17:55 Education/ACR/EULAR General Rheumatology Drs. Jack Cush and Artie Kavanaugh preview
B Cell Targeting in Idiopathic Thrombocytopenic Purpura jjcush@gmail.com Tue, 12/09/2025 – 17:50
I Can’t Believe it’s Not Seronegative Rheumatoid Arthritis?! daricmueller@g… Tue, 12/09/2025 – 17:50
APPs in the news (12.5.2025) Dr. Jack Cush reviews the news and journal reports from https://t.co/V10S4oVFsv, includin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue,
Rheumatologists often prescribe glucocorticoids at lower doses than oncology guidelines recommend. These findings suggest that glucocorticoid …
1. Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, UK; 2. School of Infection, Inflammation and Immunology, …
J Investig Allergol Clin Immunol. 2025 Dec 9:0. doi: 10.18176/jiaci.1131. Online ahead of print. NO ABSTRACT PMID:41364385 | DOI:10.18176/jiaci.1131
Clin Exp Nephrol. 2025 Dec 9. doi: 10.1007/s10157-025-02789-3. Online ahead of print. ABSTRACT This review series provided methodological guidance for
Clin Rheumatol. 2025 Dec 9. doi: 10.1007/s10067-025-07871-5. Online ahead of print. ABSTRACT Between April 2022 and April 2023, our group
J Physiol Pharmacol. 2025 Oct;76(5):509-523. doi: 10.26402/jpp.2025.5.03. Epub 2025 Nov 28. ABSTRACT Despite similar clinical effectiveness of tumor necrosis factor
Radiology. 2025 Dec;317(3):e252085. doi: 10.1148/radiol.252085. NO ABSTRACT PMID:41363983 | DOI:10.1148/radiol.252085
J Clin Rheumatol. 2025 Dec 9. doi: 10.1097/RHU.0000000000002302. Online ahead of print. NO ABSTRACT PMID:41363890 | DOI:10.1097/RHU.0000000000002302
J Innate Immun. 2025;17(1):522-538. doi: 10.1159/000548548. Epub 2025 Oct 31. ABSTRACT <p>Introduction: Synovial natural killer (NK) cells contribute to inflammation
J Clin Oncol. 2025 Dec 9:JCO2502380. doi: 10.1200/JCO-25-02380. Online ahead of print. ABSTRACT PURPOSE: BRUIN CLL-313 is a randomized, open-label,
J Appl Physiol (1985). 2025 Dec 9. doi: 10.1152/japplphysiol.00951.2024. Online ahead of print. ABSTRACT This study examined the effect of
Arthritis Rheumatol. 2025 Dec 9. doi: 10.1002/art.70011. Online ahead of print. NO ABSTRACT PMID:41363145 | DOI:10.1002/art.70011
Arthritis Rheumatol. 2025 Dec 9. doi: 10.1002/art.70008. Online ahead of print. ABSTRACT OBJECTIVE: Still’s disease (SD) is a rare systemic
RHEUM Survey> What is the goal for every new MSK patient evaluation? https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/09/2025 – 14:12 RheumNow Dr.
Several changes in the 2026 Medicare Physicians Fee Schedule, or PFS, will help to better support primary, preventive and comprehensive
Cross-sectional study of 79 743 US primary care practices compared those with and without NPs. NP practices were more https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Conditions: Rheumatoid Arthritis; Arthritis Interventions: Drug: JAK inhibitors and traditional treatment of rheumatoid arthritis Sponsors: Assiut University Not yet recruiting
QD Clinic: CAR-T Cell Therapy for Lupus Philip Mease, MD and Cayla Alexander, DNP, ARNP, Seattle, Washington, discuss https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
DMARD Treatment Lags for Minority Groups with Rheumatoid Arthritis Use of disease-modifying anti-rheumatic drugs (DMARD https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/09/2025 –
A 62-year-old man with gout was referred to the rheumatology department of our institution. His first flares occurred approximately 20
About one in eight adults say they are taking a GLP-1 receptor agonist as a treatment for obesity, diabetes or
Research demonstrating the effectiveness of subcutaneous anifrolumab-fnia as an auto-injector in patients with active systemic lupus erythematosus is the basis